(MENAFN- Market Press Release) October 10, 2025 10:35 am - The In Vitro Transcription Template market, valued at USD 293.7 million in 2024, is expected to register revenue CAGR of 20.5%. Request free copy of this report:

October 10, 2025- Rising demand for mRNA-based therapeutics is a key driver of revenue growth in the in vitro transcription template market. The therapeutic use of messenger RNA (mRNA) has raised high hopes for combating a wide spectrum of incurable disorders. Furthermore, in vitro transcribed mRNA has achieved planned production, which is more effective, faster to design and produce, adaptable, and cost-efficient than traditional procedures. Unlike DNA-based medications, mRNA transcripts have a relatively high transfection efficiency and low toxicity since they do not require entry into the nucleus to act.
On November 2024, Synthego has expanded its solution portfolio with the addition of high-performance RNA enzymes, T7 RNA Polymerase and RNase Inhibitor, bolstering its ability to service the RNA research and therapeutic sectors. These recently released in vitro transcription (IVT) enzymes are specifically intended to address important issues in RNA synthesis and modification, and they supplement Synthego's industry-leading gRNAs.

Despite its many benefits, in vitro transcription (IVT) faces several challenges, including issues related to enzyme specificity and efficiency, high production costs, process optimization, and the stability and shelf life of synthesized mRNA. The limited stability and short shelf life of mRNA remain major hurdles in the development, formulation, storage, and transportation of mRNA-based therapeutics.

Want to Know What's Fueling the In Vitro Transcription Template Market Growth? Get Exclusive Report Insights Here:

Segments market overview and growth Insights
Based on the product type, the in vitro transcription template market is segmented into enzymes, kits and reagents, and custom synthesis. Enzymes segment contributed the largest share in 2024. In vitro transcription enzymes are pivotal in enabling the controlled enzymatic production of RNA molecules from DNA templates in laboratory environments. Unlike biological transcription, IVT allows researchers full control over RNA sequence, length, and modifications. In January 2025, Aldevron, a global leader in DNA, RNA, and protein manufacturing, introduced Alchemy cell-free DNA technology, a major innovation in synthetic DNA production. This cell-free enzymatic process facilitates the creation of linear DNA (linDNA) templates, marking a significant leap in template synthesis efficiency and scalability.

Regional market overview and growth insights
North America held the largest market share in the In Vitro Transcription Template market in 2024. The market's growth is further supported by the rising prevalence of chronic diseases. For instance, according to the American Lung Association, cystic fibrosis affects around 40,000 people in the U.S. and 100,000 globally, with approximately 1 in 30 Americans being carriers.

Competitive Landscape and Key Competitors
The In Vitro Transcription Template market is characterized by a fragmented structure, with many competitors holding a significant share of the market. List of major players included in the In Vitro Transcription Template market report are:

oTakara Bio Inc
oBio-Synthesis Inc
oIntegrated DNA Technologies, Inc.
oTriLink BioTechnologies
oPromega Corporation
oGenScript Biotech Corporation
oNew England Biolabs
oAmsbio
oThermo Fisher Scientific Inc.
oSynthego Holdings LLC
oOZ Biosciences
oGeneCopoeia, Inc.
oCreative Biolabs
oGeneBio Systems
oF. Hoffmann-La Roche Ltd

Buy Your Exclusive Copy Now:

Major strategic developments by leading competitors
TriLink BioTechnologies: In May 2025, TriLink BioTechnologies, a Maravai LifeSciences company, announced a major contribution to academic laboratories in the U.S. and Europe, coinciding with the launch of its first mRNA synthesis kit featuring CleanCap capping technology. This all-in-one kit simplifies the mRNA synthesis workflow by integrating advanced reagents into a single, cost-effective package, underscoring ongoing innovation in the IVT field.

Eurofins Genomics Blue Heron: In June 2023, Eurofins Genomics Blue Heron introduced its advanced IVT mRNA Synthesis Services, offering researchers a comprehensive solution for custom, high-quality mRNA production with fast turnaround times. The service leverages state-of-the-art in vitro transcription (IVT) technology to enable the rapid and efficient generation of high-purity messenger RNA transcripts, meeting the growing demand for precision and reliability in mRNA research and development.

Unlock the Key to Transforming Your Business Strategy with Our In Vitro Transcription Template Market Insights –
.Download the report summary:
.Request customization:

Navistrat Analytics has segmented the In Vitro Transcription Template market based on product type, application, indication, end-use, and region:
.Product Type Outlook (Revenue, USD Million; 2022-2032)
oEnzymes
oKits and Reagents
oCustom Synthesis

.Application Outlook (Revenue, USD Million; 2022-2032)
omRNA Therapeutics and Vaccines
oGene Therapy and Cell Therapy
oRNA Research & Functional Studies
oPersonalized Medicine & Oncology
oDiagnostics
oOthers

.Indication Outlook (Revenue, USD Million; 2022-2032)
oCancer
oInfectious Disease
oLifestyle Disease
oGenetic Disease
oNeurological Disorders
oOthers

.End-Use Outlook (Revenue, USD Million; 2022-2032)
oPharmaceutical & Biotechnology Companies
oAcademic & Research Institutions
oContract Research Organizations (CROs)
oOthers

.Regional Outlook (Revenue, USD Million; 2022-2032)
oNorth Benelux
g Countries
h of Europe

oAsia Pacific
a Japan
d Oceania
f Countries
g of APAC

oLatin Brazil
b of LATAM

oMiddle East & Africa
a Countries
b Turkey
e of MEA

Get a preview of the complete research study:

About Us:
At Navistrat Analytics, we provide high-quality, comprehensive syndicated and customized market research reports that deliver actionable insights and empower businesses through data-driven strategies. Choose Navistrat Analytics as your strategic growth partner for reliable market intelligence, and let us help you navigate the complexities of the market with clarity, precision, and confidence.

Contact Us:
Navistrat Analytics
Visit Us:
Email Us: ...
Asia-Pacific: +91-9073010653
Follow Us LinkedIn:

MENAFN11102025003520003262ID1110180921